These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26892043)

  • 1. Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.
    Kawprasertsri S; Pietras RJ; Marquez-Garban DC; Boonyaratanakornkit V
    Cancer Lett; 2016 May; 374(2):279-91. PubMed ID: 26892043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptides containing the progesterone receptor polyproline domain inhibits EGF signaling and cell proliferation in lung cancer cells.
    Kaewjanthong P; Sooksai S; Sasano H; Hutvagner G; Bajan S; McGowan E; Boonyaratanakornkit V
    PLoS One; 2022; 17(3):e0264717. PubMed ID: 35235599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
    Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
    Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor-Grb2 interaction is associated with better outcomes in breast cancer.
    Wittayavimol N; Iwabuchi E; Pateetin P; Miki Y; Onodera Y; Sasano H; Boonyaratanakornkit V
    J Steroid Biochem Mol Biol; 2024 Mar; 237():106441. PubMed ID: 38070754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle.
    Boonyaratanakornkit V; McGowan E; Sherman L; Mancini MA; Cheskis BJ; Edwards DP
    Mol Endocrinol; 2007 Feb; 21(2):359-75. PubMed ID: 17138644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
    Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
    Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells.
    Campbell TM; Main MJ; Fitzgerald EM
    J Cell Sci; 2013 Nov; 126(Pt 21):4939-49. PubMed ID: 23986482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
    Faivre EJ; Daniel AR; Hillard CJ; Lange CA
    Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells.
    Giannopoulou E; Nikolakopoulos A; Kotsirilou D; Lampropoulou A; Raftopoulou S; Papadimitriou E; Theocharis AD; Makatsoris T; Fasseas K; Kalofonos HP
    J Biomed Sci; 2015 Oct; 22():98. PubMed ID: 26497899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
    Skildum A; Faivre E; Lange CA
    Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression.
    Boonyaratanakornkit V; Bi Y; Rudd M; Edwards DP
    Steroids; 2008 Oct; 73(9-10):922-8. PubMed ID: 18321550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
    Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
    Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.
    Kang HN; Kim SH; Yun MR; Kim HR; Lim SM; Kim MS; Hong KW; Kim SM; Kim H; Pyo KH; Park HJ; Han JY; Youn HA; Chang KH; Cho BC
    Lung Cancer; 2016 May; 95():57-64. PubMed ID: 27040853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway.
    Zuo L; Li W; You S
    Breast Cancer Res; 2010; 12(3):R34. PubMed ID: 20540763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.
    Liu B; Su Y; Li T; Yuan W; Mo X; Li H; He Q; Ma D; Han W
    Oncotarget; 2015 Dec; 6(38):41092-107. PubMed ID: 26528697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
    Stabile LP; Lyker JS; Gubish CT; Zhang W; Grandis JR; Siegfried JM
    Cancer Res; 2005 Feb; 65(4):1459-70. PubMed ID: 15735034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
    Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
    Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.